Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-006095
Filing Date
2017-02-06
Accepted
2017-02-06 11:30:17
Documents
1
Period of Report
2017-02-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v458451_4.html 4  
1 OWNERSHIP DOCUMENT v458451_4.xml 4 6093
  Complete submission text file 0001144204-17-006095.txt   7418
Mailing Address
Business Address
SULAT JAMES R (Reporting) CIK: 0001229448 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54986 | Film No.: 17574506

Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Issuer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 3841 Surgical & Medical Instruments & Apparatus